[1]
Sanyal, D. et al. 2022. HYPOKALAEMIA AND COMORBIDITIES ARE COMMON AT INITIAL PRESENTATION IN PATIENTS WITH PRIMARY HYPERALDOSTERONISM. Journal of the ASEAN Federation of Endocrine Societies. 37, 2 (Oct. 2022), 20. DOI:https://doi.org/10.15605/jafes.037.AFES.21.